Hoya Reports Third Quarter Financial Results

HOYA Corporation announced its financial results for the third quarter ended December 31, 2018. During the quarter, revenue increased 4.9% year on year, reaching 143,425 million yen. Profit before tax amounted to 39,676 million yen with 33,143 million yen in net profit, representing year-on-year increases of 14.4% and 19.5%, respectively. Profit before tax ratio was 27.7%, representing a year-on-year increase of 2.3 points.

In the Life Care segment, Eyeglass lens sales were strong in Japan. At the same time, steady sales growth in the Americas and other factors drove overseas sales increases on a local currency basis. However, the overall impact of currency exchange rates resulted in sales level with the same period in the prior fiscal year. New store openings of our Eyecity contact lens specialty stores, as well as new customer expansion efforts at existing stores, resulted in higher year-on-year sales for contact lenses.

Although performance was strong overseas as well, our capture of a major project in the prior year led to results that underperformed year on year. As a result, sales for the Life Care segment grew 4.2% year on year, reaching 93,902 million yen. Segment profit rose 12.9% year on year to 19,144 million yen.

“We are less impacted by the cyclicality of the semiconductor and datacenter market, enabling us secure growth on relevant products. Also, our Life Care Business is showing great stability,” said Hiroshi Suzuki, chief executive officer of HOYA. “This quarter is again a good example of our business portfolio system which allows us stable growth.”

Click HERE for the full press release.

Featured Posts

Applications for the 2023 Transitions Change Agent Program Now Open Through December 31, 2022

Become a Change Agent and make a difference with your peers and patients!

Learn More

Swarovski and EssilorLuxottica Announce Ten-year Licensing Agreement

Swarovski and EssilorLuxottica announce that they have signed an exclusive license agreement for the design, manufacture and worldwide distribution of Swarovski Eyewear.

Read more

Industry Professionals and Trainers Joined Transitions Optical for “The Studio” Educational Event, 2nd Edition

Transitions Optical gathered over 80 industry professionals for a one-of-a-kind learning train the trainer event—Transitions® The Studio—on November 8, 2022.

Read more

Bausch + Lomb Launches Biotrue® Advanced Multi-Purpose Solution in Canada

New Formula Provides More Moisture on Contact Lenses

Read more

SILMO Istanbul 2022: A Record Attendance

SILMO ISTANBUL welcomed both local manufacturers and a number of international companies of the optical and eyewear industry.

Read more

Applications for the 2023 Transitions Change Agent Program Now Open Through December 31, 2022

Become a Change Agent and make a difference with your peers and patients!

Learn More

Swarovski and EssilorLuxottica Announce Ten-year Licensing Agreement

Swarovski and EssilorLuxottica announce that they have signed an exclusive license agreement for the design, manufacture and worldwide distribution of Swarovski Eyewear.

Read More

Industry Professionals and Trainers Joined Transitions Optical for “The Studio” Educational Event, 2nd Edition

Transitions Optical gathered over 80 industry professionals for a one-of-a-kind learning train the trainer event—Transitions® The Studio—on November 8, 2022.

Read More

Bausch + Lomb Launches Biotrue® Advanced Multi-Purpose Solution in Canada

New Formula Provides More Moisture on Contact Lenses

Read More

SILMO Istanbul 2022: A Record Attendance

SILMO ISTANBUL welcomed both local manufacturers and a number of international companies of the optical and eyewear industry.

Read More

Applications for the 2023 Transitions Change Agent Program Now Open Through December 31, 2022

Become a Change Agent and make a difference with your peers and patients!

Learn More

Swarovski and EssilorLuxottica Announce Ten-year Licensing Agreement

Swarovski and EssilorLuxottica announce that they have signed an exclusive license agreement for the design, manufacture and worldwide distribution of Swarovski Eyewear.

Read more

Industry Professionals and Trainers Joined Transitions Optical for “The Studio” Educational Event, 2nd Edition

Transitions Optical gathered over 80 industry professionals for a one-of-a-kind learning train the trainer event—Transitions® The Studio—on November 8, 2022.

Read more

Bausch + Lomb Launches Biotrue® Advanced Multi-Purpose Solution in Canada

New Formula Provides More Moisture on Contact Lenses

Read more

SILMO Istanbul 2022: A Record Attendance

SILMO ISTANBUL welcomed both local manufacturers and a number of international companies of the optical and eyewear industry.

Read more

Applications for the 2023 Transitions Change Agent Program Now Open Through December 31, 2022

Become a Change Agent and make a difference with your peers and patients!

Learn More

Swarovski and EssilorLuxottica Announce Ten-year Licensing Agreement

Swarovski and EssilorLuxottica announce that they have signed an exclusive license agreement for the design, manufacture and worldwide distribution of Swarovski Eyewear.

Read more

Industry Professionals and Trainers Joined Transitions Optical for “The Studio” Educational Event, 2nd Edition

Transitions Optical gathered over 80 industry professionals for a one-of-a-kind learning train the trainer event—Transitions® The Studio—on November 8, 2022.

Read more

Bausch + Lomb Launches Biotrue® Advanced Multi-Purpose Solution in Canada

New Formula Provides More Moisture on Contact Lenses

Read more

SILMO Istanbul 2022: A Record Attendance

SILMO ISTANBUL welcomed both local manufacturers and a number of international companies of the optical and eyewear industry.

Read more